OUR COMPANY
NeuroXT is a pioneering AI company redefining brain imaging with world-leading MRI-based technology.
Our Products
NEXT-Cue
NEXT-Cue is an AI-based solution that analyzes brain MRI together with clinical information to support the assessment of cognitive decline. It is designed to provide clinicians with additional insight in the care of patients at risk of Alzheimer's disease.
NEXT-SCN
World-first multimodal platform that measures in-vivo synaptic integrity to objectively verify the impact of synapse-targeted therapies.
NEXT-STAGE
MRI in, tau insight out. NEXT‑STAGE infers regional tau burden from routine MRI noninvasive, scalable, and cost‑effective. PET‑complementary, built for research teams in biopharma and academic hospitals.
